0001193125-22-225373 Sample Contracts

9,627,640 Shares of Common Stock 28,084 Shares of Series B Preferred Stock Viridian Therapeutics, Inc. UNDERWRITING AGREEMENT

Underwriting Agreement • August 19th, 2022 • Viridian Therapeutics, Inc.\DE • Services-medical laboratories • New York

• Contract Type
  Underwriting Agreement
• Filed
  August 19th, 2022
• Company
  Viridian Therapeutics, Inc.\DE
• Industry
  Services-medical laboratories
• Jurisdiction
  New York